Virginia Retirement Systems ET AL Sells 4,300 Shares of PRA Health Sciences, Inc. (PRAH)

Virginia Retirement Systems ET AL reduced its holdings in shares of PRA Health Sciences, Inc. (NASDAQ:PRAH) by 11.1% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 34,600 shares of the medical research company’s stock after selling 4,300 shares during the period. Virginia Retirement Systems ET AL owned about 0.05% of PRA Health Sciences worth $2,635,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in PRA Health Sciences by 12.0% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,488 shares of the medical research company’s stock valued at $112,000 after purchasing an additional 160 shares during the last quarter. Carroll Financial Associates Inc. lifted its holdings in PRA Health Sciences by 127.4% during the 3rd quarter. Carroll Financial Associates Inc. now owns 1,410 shares of the medical research company’s stock valued at $112,000 after purchasing an additional 790 shares during the last quarter. CAPROCK Group Inc. bought a new position in PRA Health Sciences during the 2nd quarter valued at about $208,000. Comerica Bank bought a new position in PRA Health Sciences during the 3rd quarter valued at about $214,000. Finally, Trustmark National Bank Trust Department bought a new position in PRA Health Sciences during the 2nd quarter valued at about $225,000. Institutional investors and hedge funds own 98.51% of the company’s stock.

In other news, Director Matthew P. Young sold 5,115 shares of PRA Health Sciences stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $79.90, for a total transaction of $408,688.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 2.10% of the stock is owned by insiders.

PRA Health Sciences, Inc. (PRAH) opened at $81.85 on Friday. PRA Health Sciences, Inc. has a 12 month low of $51.16 and a 12 month high of $84.38. The firm has a market cap of $5,186.83, a PE ratio of 30.09, a price-to-earnings-growth ratio of 1.42 and a beta of 0.41. The company has a debt-to-equity ratio of 1.38, a current ratio of 1.01 and a quick ratio of 1.01.

PRA Health Sciences (NASDAQ:PRAH) last announced its earnings results on Wednesday, October 25th. The medical research company reported $0.88 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.85 by $0.03. PRA Health Sciences had a net margin of 5.64% and a return on equity of 21.66%. The company had revenue of $494.55 million during the quarter, compared to the consensus estimate of $477.89 million. During the same period in the previous year, the firm posted $0.64 earnings per share. The company’s revenue was up 23.7% on a year-over-year basis. sell-side analysts anticipate that PRA Health Sciences, Inc. will post 3.2 EPS for the current year.

Several brokerages recently issued reports on PRAH. Zacks Investment Research downgraded shares of PRA Health Sciences from a “buy” rating to a “hold” rating in a report on Friday, September 15th. SunTrust Banks reaffirmed a “buy” rating and issued a $101.00 target price on shares of PRA Health Sciences in a research note on Friday, October 27th. KeyCorp reaffirmed a “buy” rating and issued a $93.00 target price (up from $86.00) on shares of PRA Health Sciences in a research note on Monday, October 30th. Citigroup reaffirmed a “buy” rating and issued a $93.00 target price (up from $90.00) on shares of PRA Health Sciences in a research note on Thursday, August 10th. Finally, Mizuho set a $87.00 target price on shares of PRA Health Sciences and gave the stock a “buy” rating in a research note on Friday. One equities research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. PRA Health Sciences has an average rating of “Buy” and a consensus target price of $89.09.

COPYRIGHT VIOLATION WARNING: This article was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international trademark and copyright law. The legal version of this article can be read at https://www.com-unik.info/2017/12/03/virginia-retirement-systems-et-al-sells-4300-shares-of-pra-health-sciences-inc-prah.html.

PRA Health Sciences Company Profile

PRA Health Sciences, Inc is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases.

Institutional Ownership by Quarter for PRA Health Sciences (NASDAQ:PRAH)

What are top analysts saying about PRA Health Sciences Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for PRA Health Sciences Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit